1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Genetic Disease Diagnostic Market Size Growth Rate by Type: 2018 VS 2022 VS 2029 1.2.2 Prenatal Diagnosis 1.2.3 Screening for Single Gene Genetic Disease 1.2.4 Preimplantation Genetic Testing 1.2.5 Others 1.3 Market by Application 1.3.1 Global Genetic Disease Diagnostic Market Growth by Application: 2018 VS 2022 VS 2029 1.3.2 Hospital 1.3.3 Medical Laboratory 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 1.6 Years Considered 2 Global Growth Trends 2.1 Global Genetic Disease Diagnostic Market Perspective (2018-2029) 2.2 Genetic Disease Diagnostic Growth Trends by Region 2.2.1 Global Genetic Disease Diagnostic Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Genetic Disease Diagnostic Historic Market Size by Region (2018-2023) 2.2.3 Genetic Disease Diagnostic Forecasted Market Size by Region (2024-2029) 2.3 Genetic Disease Diagnostic Market Dynamics 2.3.1 Genetic Disease Diagnostic Industry Trends 2.3.2 Genetic Disease Diagnostic Market Drivers 2.3.3 Genetic Disease Diagnostic Market Challenges 2.3.4 Genetic Disease Diagnostic Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Genetic Disease Diagnostic Players by Revenue 3.1.1 Global Top Genetic Disease Diagnostic Players by Revenue (2018-2023) 3.1.2 Global Genetic Disease Diagnostic Revenue Market Share by Players (2018-2023) 3.2 Global Genetic Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Genetic Disease Diagnostic Revenue 3.4 Global Genetic Disease Diagnostic Market Concentration Ratio 3.4.1 Global Genetic Disease Diagnostic Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Genetic Disease Diagnostic Revenue in 2022 3.5 Genetic Disease Diagnostic Key Players Head office and Area Served 3.6 Key Players Genetic Disease Diagnostic Product Solution and Service 3.7 Date of Enter into Genetic Disease Diagnostic Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Genetic Disease Diagnostic Breakdown Data by Type 4.1 Global Genetic Disease Diagnostic Historic Market Size by Type (2018-2023) 4.2 Global Genetic Disease Diagnostic Forecasted Market Size by Type (2024-2029) 5 Genetic Disease Diagnostic Breakdown Data by Application 5.1 Global Genetic Disease Diagnostic Historic Market Size by Application (2018-2023) 5.2 Global Genetic Disease Diagnostic Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Genetic Disease Diagnostic Market Size (2018-2029) 6.2 North America Genetic Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029 6.3 North America Genetic Disease Diagnostic Market Size by Country (2018-2023) 6.4 North America Genetic Disease Diagnostic Market Size by Country (2024-2029) 6.5 United States 6.6 Canada 7 Europe 7.1 Europe Genetic Disease Diagnostic Market Size (2018-2029) 7.2 Europe Genetic Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 Europe Genetic Disease Diagnostic Market Size by Country (2018-2023) 7.4 Europe Genetic Disease Diagnostic Market Size by Country (2024-2029) 7.5 Germany 7.6 France 7.7 U.K. 7.8 Italy 7.9 Russia 7.10 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Genetic Disease Diagnostic Market Size (2018-2029) 8.2 Asia-Pacific Genetic Disease Diagnostic Market Growth Rate by Region: 2018 VS 2022 VS 2029 8.3 Asia-Pacific Genetic Disease Diagnostic Market Size by Region (2018-2023) 8.4 Asia-Pacific Genetic Disease Diagnostic Market Size by Region (2024-2029) 8.5 China 8.6 Japan 8.7 South Korea 8.8 Southeast Asia 8.9 India 8.10 Australia 9 Latin America 9.1 Latin America Genetic Disease Diagnostic Market Size (2018-2029) 9.2 Latin America Genetic Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Latin America Genetic Disease Diagnostic Market Size by Country (2018-2023) 9.4 Latin America Genetic Disease Diagnostic Market Size by Country (2024-2029) 9.5 Mexico 9.6 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Genetic Disease Diagnostic Market Size (2018-2029) 10.2 Middle East & Africa Genetic Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Middle East & Africa Genetic Disease Diagnostic Market Size by Country (2018-2023) 10.4 Middle East & Africa Genetic Disease Diagnostic Market Size by Country (2024-2029) 10.5 Turkey 10.6 Saudi Arabia 10.7 UAE 11 Key Players Profiles 11.1 Abbott 11.1.1 Abbott Company Detail 11.1.2 Abbott Business Overview 11.1.3 Abbott Genetic Disease Diagnostic Introduction 11.1.4 Abbott Revenue in Genetic Disease Diagnostic Business (2018-2023) 11.1.5 Abbott Recent Development 11.2 PerkinElmer 11.2.1 PerkinElmer Company Detail 11.2.2 PerkinElmer Business Overview 11.2.3 PerkinElmer Genetic Disease Diagnostic Introduction 11.2.4 PerkinElmer Revenue in Genetic Disease Diagnostic Business (2018-2023) 11.2.5 PerkinElmer Recent Development 11.3 Roche Diagnostics 11.3.1 Roche Diagnostics Company Detail 11.3.2 Roche Diagnostics Business Overview 11.3.3 Roche Diagnostics Genetic Disease Diagnostic Introduction 11.3.4 Roche Diagnostics Revenue in Genetic Disease Diagnostic Business (2018-2023) 11.3.5 Roche Diagnostics Recent Development 11.4 Bio Rad 11.4.1 Bio Rad Company Detail 11.4.2 Bio Rad Business Overview 11.4.3 Bio Rad Genetic Disease Diagnostic Introduction 11.4.4 Bio Rad Revenue in Genetic Disease Diagnostic Business (2018-2023) 11.4.5 Bio Rad Recent Development 11.5 Thermo Fisher Scientific 11.5.1 Thermo Fisher Scientific Company Detail 11.5.2 Thermo Fisher Scientific Business Overview 11.5.3 Thermo Fisher Scientific Genetic Disease Diagnostic Introduction 11.5.4 Thermo Fisher Scientific Revenue in Genetic Disease Diagnostic Business (2018-2023) 11.5.5 Thermo Fisher Scientific Recent Development 11.6 BGI Group 11.6.1 BGI Group Company Detail 11.6.2 BGI Group Business Overview 11.6.3 BGI Group Genetic Disease Diagnostic Introduction 11.6.4 BGI Group Revenue in Genetic Disease Diagnostic Business (2018-2023) 11.6.5 BGI Group Recent Development 11.7 Berry Genomics 11.7.1 Berry Genomics Company Detail 11.7.2 Berry Genomics Business Overview 11.7.3 Berry Genomics Genetic Disease Diagnostic Introduction 11.7.4 Berry Genomics Revenue in Genetic Disease Diagnostic Business (2018-2023) 11.7.5 Berry Genomics Recent Development 11.8 Da An Gene Co., Ltd. 11.8.1 Da An Gene Co., Ltd. Company Detail 11.8.2 Da An Gene Co., Ltd. Business Overview 11.8.3 Da An Gene Co., Ltd. Genetic Disease Diagnostic Introduction 11.8.4 Da An Gene Co., Ltd. Revenue in Genetic Disease Diagnostic Business (2018-2023) 11.8.5 Da An Gene Co., Ltd. Recent Development 11.9 Illumina 11.9.1 Illumina Company Detail 11.9.2 Illumina Business Overview 11.9.3 Illumina Genetic Disease Diagnostic Introduction 11.9.4 Illumina Revenue in Genetic Disease Diagnostic Business (2018-2023) 11.9.5 Illumina Recent Development 11.10 CapitalBio Technology 11.10.1 CapitalBio Technology Company Detail 11.10.2 CapitalBio Technology Business Overview 11.10.3 CapitalBio Technology Genetic Disease Diagnostic Introduction 11.10.4 CapitalBio Technology Revenue in Genetic Disease Diagnostic Business (2018-2023) 11.10.5 CapitalBio Technology Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details